Cargando…
Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
Cognitive symptoms of schizophrenia are reported to be minimally responsive to treatment with antipsychotic medications, though variability exists and many prior studies have significant confounds. Here, we examined the response of cognitive symptoms to antipsychotic medications in 71 inpatients wit...
Autores principales: | Blackman, Rachael K., Dickinson, Dwight, Eisenberg, Daniel P., Gregory, Michael D., Apud, José A., Berman, Karen F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602047/ https://www.ncbi.nlm.nih.gov/pubmed/34820293 http://dx.doi.org/10.1016/j.scog.2021.100223 |
Ejemplares similares
-
The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia
por: Richards, Alexander L, et al.
Publicado: (2020) -
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia
por: Legge, Sophie E., et al.
Publicado: (2021) -
COMT Val158Met polymorphism, cognitive stability and cognitive flexibility: an experimental examination
por: Rosa, Elise C, et al.
Publicado: (2010) -
Polygenic scores for schizophrenia and general cognitive ability: associations with six cognitive domains, premorbid intelligence, and cognitive composite score in individuals with a psychotic disorder and in healthy controls
por: Engen, Magnus Johan, et al.
Publicado: (2020) -
Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2013)